Two COVID-19 antibody therapies are no longer recommended by the World Health Organization (WHO), on the basis that Omicron and the variant's latest offshoots have likely rendered them obsolete. www.reuters.com/business/healthcare-pharmaceuticals/who-strongly-advises-against-use-two-covid-treatments-2022-09-15/? The two therapies - which are designed to work by...

Despite the fact that they’re driving a spurt in COVID cases, the World Health Organization (WHO) says XBB and BQ.1 are not different enough from each other, or from other Omicron lineages, to warrant labelling them new variants of...